 |
PDBsum entry 1k8a
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
237 a.a.
|
 |
|
|
|
|
|
|
|
337 a.a.
|
 |
|
|
|
|
|
|
|
246 a.a.
|
 |
|
|
|
|
|
|
|
140 a.a.
|
 |
|
|
|
|
|
|
|
172 a.a.
|
 |
|
|
|
|
|
|
|
119 a.a.
|
 |
|
|
|
|
|
|
|
29 a.a.
|
 |
|
|
|
|
|
|
|
156 a.a.
|
 |
|
|
|
|
|
|
|
142 a.a.
|
 |
|
|
|
|
|
|
|
132 a.a.
|
 |
|
|
|
|
|
|
|
145 a.a.
|
 |
|
|
|
|
|
|
|
194 a.a.
|
 |
|
|
|
|
|
|
|
186 a.a.
|
 |
|
|
|
|
|
|
|
115 a.a.
|
 |
|
|
|
|
|
|
|
143 a.a.
|
 |
|
|
|
|
|
|
|
95 a.a.
|
 |
|
|
|
|
|
|
|
150 a.a.
|
 |
|
|
|
|
|
|
|
81 a.a.
|
 |
|
|
|
|
|
|
|
119 a.a.
|
 |
|
|
|
|
|
|
|
53 a.a.
|
 |
|
|
|
|
|
|
|
65 a.a.
|
 |
|
|
|
|
|
|
|
154 a.a.
|
 |
|
|
|
|
|
|
|
82 a.a.
|
 |
|
|
|
|
|
|
|
142 a.a.
|
 |
|
|
|
|
|
|
|
73 a.a.
|
 |
|
|
|
|
|
|
|
56 a.a.
|
 |
|
|
|
|
|
|
|
46 a.a.
|
 |
|
|
|
|
|
|
|
92 a.a.
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
__K
×3
|
 |
|
|
|
|
|
|
|
_NA
×83
|
 |
|
|
|
|
|
|
|
_CL
×23
|
 |
|
|
|
|
|
|
|
_MG
×119
|
 |
|
|
|
|
|
|
|
_CD
×5
|
 |
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
The structures of four macrolide antibiotics bound to the large ribosomal subunit.
|
 |
|
Authors
|
 |
J.L.Hansen,
J.A.Ippolito,
N.Ban,
P.Nissen,
P.B.Moore,
T.A.Steitz.
|
 |
|
Ref.
|
 |
Mol Cell, 2002,
10,
117-128.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
 |
|
Abstract
|
 |
|
Crystal structures of the Haloarcula marismortui large ribosomal subunit
complexed with the 16-membered macrolide antibiotics carbomycin A, spiramycin,
and tylosin and a 15-membered macrolide, azithromycin, show that they bind in
the polypeptide exit tunnel adjacent to the peptidyl transferase center. Their
location suggests that they inhibit protein synthesis by blocking the egress of
nascent polypeptides. The saccharide branch attached to C5 of the lactone rings
extends toward the peptidyl transferase center, and the isobutyrate extension of
the carbomycin A disaccharide overlaps the A-site. Unexpectedly, a reversible
covalent bond forms between the ethylaldehyde substituent at the C6 position of
the 16-membered macrolides and the N6 of A2103 (A2062, E. coli). Mutations in
23S rRNA that result in clinical resistance render the binding site less
complementary to macrolides.
|
 |
 |
 |
|
 |
|
 |
Figure 1.
Figure 1. Chemical Structures of the Macrolides, Tylosin,
Carbomycin A, Spiramycin, Azithromycin, and ErythromycinAtoms in
these figures and in the Protein Data Bank coordinate files
(1K8A, 1K9M, 1M1K, and 1KD1) are named according to Paesen et
al. (1995), with the numbering of the atoms of the lactone ring
starting at the ester bond. Oxygen atoms are numbered according
to the adjacent carbon atoms, and sugar atom numbers are
modified by suffixes A, B, or C to distinguish mycaminose,
mycarose, and any additional sugar, respectively.
|
 |
Figure 5.
Figure 5. Comparison of the Interactions of Different
Macrolides with the Ribosome(A) Carbomycin (red), tylosin
(orange), spiramycin (yellow), and azithromycin (blue) bind the
ribosome in an almost identical fashion and cover G2099 (A2058)
and A2100 (2059) (green spheres). The lactone ring is extended
further into the tunnel by mycinose on tylosin and forosamine on
spiramycin. The disaccharide moiety extends the 16-membered
macrolides in the opposite direction toward the catalytic
center. Upon 16-membered macrolide binding (but not
azithromycin), the base of A2103 (2062) (dark green) moves
(curved white line) from its location against the wall of the
exit tunnel to an extended conformation (light green sticks) and
forms a covalent bond with the macrolide (orange sticks). The
isobutyrate group of carbomycin A (red) reaches into the tRNA
A-site (dark blue and purple spheres). The mycinose moiety of
tylosin (orange) contacts protein L22. The forosamine moiety of
spiramycin (yellow) contacts L4. The cladinose sugar of
azithromycin binds in a fourth sugar binding pocket. These three
macrolides were aligned by least squares superimposition of the
phosphates of ribosomal RNA.(B) Alignment of erythromycin
(white) bound to the D. radiodurans large subunit
(Schlünzen et al., 2001) with azithromycin (blue) bound to
the H. marismortui large subunit.
|
 |
|
 |
 |
|
The above figures are
reprinted
by permission from Cell Press:
Mol Cell
(2002,
10,
117-128)
copyright 2002.
|
 |
|
Secondary reference #1
|
 |
|
Title
|
 |
The complete atomic structure of the large ribosomal subunit at 2.4 a resolution.
|
 |
|
Authors
|
 |
N.Ban,
P.Nissen,
J.Hansen,
P.B.Moore,
T.A.Steitz.
|
 |
|
Ref.
|
 |
Science, 2000,
289,
905-920.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
 |
|
|
 |
 |
 |
|
 |
|
 |
Figure 1.
Fig. 1. Portions of the experimental 2.4 Å resolution
electron density map. (A) A stereo view of a junction between
23S rRNA domains II, III, IV, and V having a complex structure
that is clearly interpretable. The electron density is contoured
at 2 . The
bases are white and the backbones are colored by domain as
specified in Fig. 4. (B) The extended region of L3 interacting
with its surrounding RNA, where the red RNA density is contoured
at 2 and the
blue protein density is contoured at 1.5 . (C)
Detail in the L2 region showing a bound Mg2+ ion. (D) Detail
from L2 showing amino acid side chains. (E) Helices 94 through
97 from domain VI. The red contour level is at 2 , and the
yellow contour at 6 shows the
positions of the higher electron density phosphate groups.
|
 |
Figure 2.
Fig. 2. The H. marismortui large ribosomal subunit in the
rotated crown view. The L7/L12 stalk is to the right, the L1
stalk is to the left, and the central protuberance (CP) is at
the top. In this view, the surface of the subunit that interacts
with the small subunit faces the reader. RNA is shown in gray in
a pseudo-space-filling rendering. The backbones of the proteins
visible are rendered in gold. The Yarus inhibitor bound to the
peptidyl transferase site of the subunit is indicated in green
(64). The particle is approximately 250 Å across.
|
 |
|
 |
 |
|
The above figures are
reproduced from the cited reference
with permission from the AAAs
|
 |
|
Secondary reference #2
|
 |
|
Title
|
 |
The structural basis of ribosome activity in peptide bond synthesis.
|
 |
|
Authors
|
 |
P.Nissen,
J.Hansen,
N.Ban,
P.B.Moore,
T.A.Steitz.
|
 |
|
Ref.
|
 |
Science, 2000,
289,
920-930.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
 |
|
|
 |
 |
 |
|
 |
|
 |
Figure 1.
Fig. 1. Chemical structures of ribosome peptidyl transferase
substrates and analogs. (A) The tetrahedral carbon intermediate
produced during peptide bond formation; the tetrahedral carbon
is indicated by an arrow. (B) The transition state analog formed
by coupling the 3' OH of CCdA to the amino group of the O-methyl
tyrosine residue of puromycin via a phosphate group, CCdA-p-Puro
(a gift from Michael Yarus) (32). (C) An N-amino-acylated
mini-helix constructed to target the A-site. The oligonucleotide
sequence 5'-CCGGCGGGCUGGUUCAAACCGGCCCGCCGGA- CC-3' puromycin
should form 13 base pairs. The construct is based on a
mini-helix known to be a suitable substrate for amino-acylation
by Tyr-tRNA synthetase. The 3' OH of its terminal C is coupled
to the 5' OH of the N6-dimethyl A moiety of puromycin by a
phosphodiester bond.
|
 |
Figure 7.
Fig. 7. Conserved nucleotides in the peptidyl transferase
region with bound CCdA-p-Puro. A space-filling representation of
the active site region with the Yarus inhibitor viewed down the
active site cleft. All atoms belonging to 23S rRNA nucleotides
that are >95% conserved in all three kingdoms (44) are colored
red and all other nucleotides are white; the inhibitor is
colored blue.
|
 |
|
 |
 |
|
The above figures are
reproduced from the cited reference
with permission from the AAAs
|
 |
|
|
|
|
 |